Have you recently undergone weight-loss surgery
Women should discontinue tirzepatide when pregnancy is recognized and consider stopping at least one month before planned conception
If fatigue is accompanied by persistent sadness, loss of interest in activities, feelings of worthlessness, or thoughts of self-harm, seek medical attention immediately
BI 456906 (survodutide), developed as a dual agonist for GLP-1 and glucagon receptors for the treatment of obesity and NASH, is structurally modified from glucagon [109]
Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site
The incidence varies by specific agent, dose, and individual patient factors